Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001415889-25-000009
Filing Date
2025-01-02
Accepted
2025-01-02 09:21:46
Documents
2
Period of Report
2025-01-01

Document Format Files

Seq Description Document Type Size
1 form3-01022025_020143.html 3  
1 form3-01022025_020143.xml 3 4524
2 ex24-01022025_020144.htm EX-24 6888
  Complete submission text file 0001415889-25-000009.txt   12902
Mailing Address C/O LAVA THERAPEUTICS BV YALEAAN 62 3584 CM ULTRECHT P7 3585 CM
Business Address
Morris Charles Q (Reporting) CIK: 0001489966 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40241 | Film No.: 25500450

Mailing Address YALELAAN 62 UTRECHT P7 3584 CM
Business Address YALELAAN 62 UTRECHT P7 3584 CM 31 6 3000 3035
LAVA Therapeutics NV (Issuer) CIK: 0001840748 (see all company filings)

EIN.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)